Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

Ani Marrs

Senior Marketing Manager - Entellect

About the author: I’m currently responsible for Entellect – Elsevier’s data integration platform, designed to help pharma, chemicals and other Life Science organisations by enriching and harmonizing proprietary and external data so that their researchers can focus on answering the bigger questions that will improve patient outcomes. I’m particularly interested in the increase in predictive analytics within drug discovery, FAIR data and how new insights can be gleaned when information is connected across silos.

Posts by Ani Marrs

How can we get pharma R&D to embrace FAIR data?

Posted on January 6th, 2020 in Pharma R&D

FAIR data, which is Findable, Accessible, Interoperable and Reusable, has the power to transform the analyses enabling drug discovery and development—yet, the pharma industry has been slow to adopt it. There are a number of reasons for this unfortunate reality, but there is a path to realizing the potential for FAIR data in pharmaceutical R&D.


  1. 1
  2. 2
  3. 3